160 related articles for article (PubMed ID: 27898656)
1. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
Hübner J; Waldmann A; Geller AC; Weinstock MA; Eisemann N; Noftz M; Bertram S; Nolte S; Volkmer B; Greinert R; Breitbart E; Katalinic A
Br J Cancer; 2017 Jan; 116(2):253-259. PubMed ID: 27898656
[TBL] [Abstract][Full Text] [Related]
2. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening.
Waldmann A; Nolte S; Weinstock MA; Breitbart EW; Eisemann N; Geller AC; Greinert R; Volkmer B; Katalinic A
Br J Cancer; 2012 Feb; 106(5):970-4. PubMed ID: 22294187
[TBL] [Abstract][Full Text] [Related]
3. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening.
Hübner J; Waldmann A; Eisemann N; Noftz M; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
Eur J Cancer Prev; 2018 Nov; 27(6):563-569. PubMed ID: 28692584
[TBL] [Abstract][Full Text] [Related]
4. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
5. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
Eisemann N; Waldmann A; Holleczek B; Katalinic A
J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
[TBL] [Abstract][Full Text] [Related]
6. Incidence and characteristics of thick second primary melanomas: a study of the German Central Malignant Melanoma Registry.
Gassenmaier M; Stec T; Keim U; Leiter U; Eigentler TK; Metzler G; Garbe C
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):63-70. PubMed ID: 30051517
[TBL] [Abstract][Full Text] [Related]
7. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
8. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
9. The effect of screening on melanoma incidence and biopsy rates.
Whiteman DC; Olsen CM; MacGregor S; Law MH; Thompson B; Dusingize JC; Green AC; Neale RE; Pandeya N;
Br J Dermatol; 2022 Oct; 187(4):515-522. PubMed ID: 35531668
[TBL] [Abstract][Full Text] [Related]
10. A 10-Year Follow-Up Study of Subjects Recruited in a Health Campaign for the Early Diagnosis of Cutaneous Melanoma: Suggestions for the Screening Timetable.
Cristofolini M; Boi S; Cattoni D; Sicher MC; Decarli A; Micciolo R
Dermatology; 2015; 231(4):345-52. PubMed ID: 26278413
[TBL] [Abstract][Full Text] [Related]
11. Melanoma mortality following skin cancer screening in Germany.
Boniol M; Autier P; Gandini S
BMJ Open; 2015 Sep; 5(9):e008158. PubMed ID: 26373399
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
13. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
Katalinic A; Kunze U; Schäfer T
Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
[TBL] [Abstract][Full Text] [Related]
15. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study.
Moloney FJ; Guitera P; Coates E; Haass NK; Ho K; Khoury R; O'Connell RL; Raudonikis L; Schmid H; Mann GJ; Menzies SW
JAMA Dermatol; 2014 Aug; 150(8):819-27. PubMed ID: 24964862
[TBL] [Abstract][Full Text] [Related]
16. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study.
Carli P; Nardini P; Crocetti E; De Giorgi V; Giannotti B
Melanoma Res; 2004 Oct; 14(5):403-7. PubMed ID: 15457097
[TBL] [Abstract][Full Text] [Related]
17. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013.
Katalinic A; Eisemann N; Waldmann A
Dtsch Arztebl Int; 2015 Sep; 112(38):629-34. PubMed ID: 26429634
[TBL] [Abstract][Full Text] [Related]
18. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]